Altman Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,950
| Closed | -$1.92M | – | 77 |
|
|
2024
Q1 | $1.92M | Buy |
13,950
+376
| +3% | +$51.9K | 0.94% | 35 |
|
|
2023
Q4 | $1.68M | Buy |
13,574
+264
| +2% | +$32.8K | 0.88% | 37 |
|
|
2023
Q3 | $1.24M | Buy |
+13,310
| New | +$1.24M | 0.78% | 69 |
|
|
2023
Q1 | $1.35M | Buy |
13,237
+242
| +2% | +$24.8K | 1.24% | 27 |
|
|
2022
Q4 | $1.38M | Sell |
12,995
-961
| -7% | -$102K | 0.85% | 45 |
|
|
2022
Q3 | $1.12M | Buy |
13,956
+418
| +3% | +$33.7K | 0.71% | 56 |
|
|
2022
Q2 | $1.2M | Buy |
13,538
+106
| +0.8% | +$9.36K | 0.68% | 69 |
|
|
2022
Q1 | $1.72M | Sell |
13,432
-8,792
| -40% | -$1.12M | 0.89% | 35 |
|
|
2021
Q4 | $2.35M | Buy |
22,224
+548
| +3% | +$57.8K | 1.43% | 30 |
|
|
2021
Q3 | $3.38M | Buy |
21,676
+164
| +0.8% | +$25.6K | 1.87% | 15 |
|
|
2021
Q2 | $2.78M | Buy |
21,512
+1,284
| +6% | +$166K | 1.57% | 21 |
|
|
2021
Q1 | $1.82M | Sell |
20,228
-1,104
| -5% | -$99.1K | 1.17% | 39 |
|
|
2020
Q4 | $1.97M | Buy |
21,332
+360
| +2% | +$33.3K | 1.24% | 37 |
|
|
2020
Q3 | $2.16M | Buy |
20,972
+448
| +2% | +$46.2K | 1.53% | 27 |
|
|
2020
Q2 | $2.08M | Buy |
20,524
+4,328
| +27% | +$439K | 1.77% | 25 |
|
|
2020
Q1 | $1.09M | Buy |
+16,196
| New | +$1.09M | 1.01% | 39 |
|
|
2018
Q3 | – | Sell |
-18,240
| Closed | -$291 | – | 73 |
|
|
2018
Q2 | $291 | Buy |
+18,240
| New | +$291 | 0.27% | 60 |
|